PTK6 and breast carcinoma: When Brk levels were suppressed in the breast cancer cell line GI101 (Figure 2A), the cells again became more susceptible to the effects of paclitaxel or doxorubicin (Figure 2D,E) compared with cells transfected with the control siRNAs.